The first sign of trouble came in 2008, when both New York and California attempted to block 23andMe from providing genetic testing without a physician’s approval. In other words, doctors didn't like the idea that patients would have more information than they did.
In time, 23andMe was able to circumvent this attempt at regulatory blockage by securing the licenses required and they continued to improve their offering. Then, in 2012, the US Food and Drug Administration finally intervened to block 23andMe from offering medical information to subscribers. It justified this action by making the bogus claim that the company’s service wasn't actually a service but was really a medical device, which meant they needed FDA approval before they could continue.